Eupraxia Pharmaceuticals is a public, clinical-stage biotechnology company focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need.
DiffuSphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians are wanting to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the DiffuSphere™ technology, versus the peaks and troughs seen with more traditional drug delivery methods.
The precision of Eupraxia's DiffuSphere™ technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, to also be applicable in oncology, infectious disease and other critical disease areas.
Company Details
- Employees
- 44
- Founded
- -
- Address
- 2590 Cadboro Bay Rd, Victoria,british Columbia,canada
- Industry
- Biotechnology
- Website
- eupraxiapharmaceuticals.com
- Keywords
- Specialist jobs.
- HQ
- Victoria, British Columbia
Eupraxia Pharmaceuticals Inc. Questions
Eupraxia Pharmaceuticals Inc.'s website is eupraxiapharmaceuticals.com
Eupraxia Pharmaceuticals Inc.'s LinkedIn profile is https://ca.linkedin.com/company/eupraxia-pharmaceuticals-inc-
Eupraxia Pharmaceuticals Inc. has
44 employees.
View email and phone details for 44
employees at Eupraxia Pharmaceuticals Inc..
Eupraxia Pharmaceuticals Inc.'s industry is
Biotechnology
Eupraxia Pharmaceuticals Inc.'s top competitors are
Aurinia Pharmaceuticals Inc.,
Eupraxia Centre For Clinical Excellence,
Zymeworks Inc.,
Abcellera,
Abdera Therapeutics,
Xenon Pharmaceuticals Inc.,
Aspect Biosystems,
Nervgen Pharma Corp.,
Life Sciences Bc,
Acuitas Therapeutics.
Eupraxia Pharmaceuticals Inc.'s categories are Biotechnology
Eupraxia Pharmaceuticals Inc.'s founding year is 2012
